Related Experiment Video
Updated: Jun 10, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.0K
Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant Staphylococcus aureus
Yajing Xu1, Tao Yang1, Yao Miao1
1School of Materials Science and Engineering, Zhejiang University, Hangzhou 310058, Zhejiang, China.
ACS Applied Materials & Interfaces
|March 30, 2024
Summary
Phage-loaded microparticles offer a novel approach to combat antibiotic-resistant bacteria. These microparticles effectively deliver lytic phages to infection sites, reducing bacterial load and demonstrating biocompatibility.
Area of Science:
- Biotechnology
- Infectious Diseases
- Materials Science
Background:
- Bacterial multidrug antibiotic resistance poses a significant public health threat.
- Lytic phages are a promising alternative to conventional antibiotics.
- Effective delivery systems for phage therapy are needed.
Purpose of the Study:
- To develop injectable phage-loaded microparticles (Phage-MPs) for targeted delivery and controlled release of lytic phages.
- To evaluate the efficacy of Phage-MPs against methicillin-resistant Staphylococcus aureus (MRSA) infections.
- To assess the biodistribution and biocompatibility of Phage-MPs.
Main Methods:
- Phages were electrostatically attached to porous polyethylenimine-modified silk fibroin microparticles (SF-MPs).
- Phage loading capacity was determined.
- In vitro and in vivo studies were conducted using a mouse abdominal MRSA infection model.
- Antibacterial activity, phage release profile, biodistribution, and biocompatibility were assessed.
Main Results:
- SF-MPs efficiently loaded phages, achieving high phage-loading capacity.
- Phage-MPs demonstrated controlled phage release and potent antibacterial activity against MRSA.
- Intraperitoneal injection of Phage-MPs resulted in sustained local phage concentration compared to free phages.
- Phage-MPs significantly reduced bacterial load in infected organs and showed excellent in vitro and in vivo biocompatibility.
Conclusions:
- Phage-loaded microparticles represent a viable strategy for delivering lytic phages to combat antibiotic-resistant bacterial infections.
- This novel delivery system enhances therapeutic efficacy by ensuring sustained local phage concentration.
- Phage-MPs show potential for a new generation of phage-based antibacterial therapies.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...